
201 - 500 employees
Founded 1998
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
💰 $450M Post-IPO Debt on 2022-06
Biotechnology • Pharmaceuticals • Healthcare Insurance
Cytokinetics is a late-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of potential medicines aimed at improving muscle function. The company is particularly active in developing treatments for cardiovascular and neuromuscular diseases, such as heart failure, hypertrophic cardiomyopathy, and other conditions of impaired muscle function. Cytokinetics has a robust pipeline of small molecule muscle activators and inhibitors and is committed to improving patients' lives through its scientific research and development efforts. The company's mission revolves around empowering muscle and thereby empowering lives, with patients being the central focus of its activities. Based in South San Francisco, Cytokinetics has been pioneering the field of muscle biology for over 25 years.
🕒 April 23
Key Account and Access Manager at Cytokinetics driving access and adoption of therapies in UK healthcare. Engaging with NHS for market access while exceeding performance metrics.